BRII-B (02137.HK) plans to hold a Board of Directors meeting on March 21 to approve the annual performance.

Glory Financial reported on March 10 that BRII-B (02137.HK) announced that a Board of Directors meeting will be held on March 21, 2025 (Friday) to review and approve the annual performance report for the year ending December 31, 2024, along with its publication, as well as to address Other matters.

Gelonghui FinanceMar 10 16:49

BRII-B: DATE OF BOARD MEETING

HKEXMar 10 16:34 · Announcements

Market Update | CloudTop New Shine's stock rises over 16%, breakthroughs in AI pharmaceutical development, and the valuation logic of Innovative Drugs in the Hong Kong stock market is changing.

① How can current AI technology break through the "double ten law" of a 10-year research and development cycle and a cost of 1 billion dollars in traditional drug development? ② The P/S of innovative drugs in the Hong Kong stock market is at a historical low, how will AI-enabled pharmaceutical companies reconstruct the valuation logic?

cls.cnMar 7 13:02

Express News | Hong Kong stocks of Nonprofit Pharmaceutical Companies are experiencing another surge, with CloudTop Bio rising over 12%, Xintong Medical rising over 9%, Tiansheng BioPharma rising over 7%, and Assembling Pharmaceuticals rising over 4%.

BreakingsMar 7 10:41

Express News | Most pharmaceutical stocks in the Hong Kong market strengthened, with ALPHAMAB-B rising over 13%.

BreakingsMar 5 09:54

The Hong Kong stock market for Medical stocks is surging! In February, the strongest has risen over 220%, what happened?

Recently, the General Office of the State Council forwarded the "2025 Action Plan for Stabilizing Foreign Investment" from the Ministry of Commerce and the National Development and Reform Commission, promoting the orderly opening of the Biomedical sector.

Futu NewsFeb 27 14:58